ERT-36130-16859
6 vaccinations
14 coded responses
76 check-ins
14 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 483 / MI
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-17
Registered in v-safe
-
2021-03-17
Dose 1 — Pfizer-BioNTech
- 2021-03-17
-
2021-03-18
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain, Reaction to previous exposure to any vaccine — Feeling: GoodFree text: Minor tenderness at injection siteno worse than annual influenza vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-31
-
2021-04-07
Dose 2 — Pfizer-BioNTech
- 2021-04-07
-
2021-04-08
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Tenderness at injection site but no worse than annual flu injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Injection site pain — Feeling: Good · Site: PainFree text: Mild tenderness at injection site and in axillary area on same side as injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain, Tenderness — Feeling: Good · Site: PainFree text: Minimal tenderness in axillary area on same side as injection; injection site tenderness has subsided/ disappeared now.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-07-07
- 2021-10-06
-
2021-11-29
Dose 3 — Pfizer-BioNTech
- 2021-11-29
- 2021-11-30
-
2021-12-01
Survey response — days 1–6 daily, dose 3MedDRA: Injection site pain, Lymphadenopathy — Feeling: Good · Site: Pain, SwellingFree text: Swelling is if axillary lymph nodes on the side of the injection; less tenderness at actual injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-12-02
Survey response — days 1–6 daily, dose 3MedDRA: Injection site pain, Lymph node pain, Lymphadenopathy, Pain in extremity — Feeling: Good · Site: Pain, SwellingFree text: Generalized arm ache/ pain greatly diminished almost gone; still tender at injection site; axillary lymph nodes remain swollen/ tender on side of injection but continues to diminishMedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Survey response — days 1–6 daily, dose 3MedDRA: Injection site pain, Lymph node pain, Lymphadenopathy, Pain in extremity — Feeling: Good · Site: Pain, SwellingFree text: Generalized arm soreness, injection site tenderness continues to diminish and almost gone; axillary lymph node on side of injection site are still swollen and tender but gradually diminishingMedDRA releases: 2024-11 · check-in free text available
-
2021-12-04
Survey response — days 1–6 daily, dose 3MedDRA: Injection site pain, Lymphadenopathy, Pain in extremity, Tenderness — Feeling: Good · Site: SwellingFree text: General arm soreness and injection site pain gone; axillary tenderness gone however lymph node swelling still present but appears to be diminishingMedDRA releases: 2024-11 · check-in free text available
-
2021-12-05
Survey response — days 1–6 daily, dose 3MedDRA: Oedema peripheral — Feeling: Good · Site: SwellingFree text: axillary swelling on side of injection continues to diminish; non- tenderMedDRA releases: 2024-11 · check-in free text available
-
2021-12-06
Survey response — day 7, dose 3MedDRA: Oedema peripheral — Feeling: Good · Site: SwellingFree text: Axillary swelling on side of the injection continues to diminish; non- tenderMedDRA releases: 2024-11 · check-in free text available
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-01-03
- 2022-01-10
- 2022-02-28
-
2022-05-19
Dose 4 — Pfizer-BioNTech
- 2022-05-19
- 2022-05-20
-
2022-05-21
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Axillary node tenderness on side of the injectionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-22
Survey response — days 1–6 daily, dose 4MedDRA: Injection site erythema, Injection site pruritus, Lymph node pain — Feeling: Good · Site: Pain, Redness, ItchingFree text: ***pinkened, itchy are surrounding injection site; axillary nodal tenderness on side of injection noted on Saturday following Thursday vaccination however not noted till after had already submitted V- safe check in; persisted thru today-lesseningMedDRA releases: 2024-11 · check-in free text available
- 2022-05-23
- 2022-05-24
-
2022-06-01
Survey response — day 7, dose 4MedDRA: Unevaluable event — Feeling: GoodFree text: I tried to answer this Thursday when it came however was away from home and your app wouldn't let me so I am answering Thursday's questions today from home.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-02
- 2022-06-09
- 2022-06-16
-
2022-06-27
Survey response — day 35, dose 4MedDRA: Bronchitis viral, Fatigue, Office visit, Productive cough, SARS-CoV-2 test negative — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: 1 week duration violent productive cough difficult to control, no fever, negative at home Covid tests, fatigue, diagnosed and treated from Urgent Care as acute viral bronchitisMedDRA releases: 2024-11 · check-in free text available
-
2022-06-27
Report sent to call center — day 35, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-28
-
2022-06-28
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-18
-
2022-09-22
Dose 5 — Pfizer-BioNTech
- 2022-09-22
-
2022-09-23
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2022-09-24
- 2022-09-25
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-10-06
- 2022-10-13
- 2022-10-24
- 2022-10-27
- 2022-11-03
- 2022-12-22
- 2023-03-25
-
2023-04-27
Dose 6 — Pfizer-BioNTech
- 2023-04-27
-
2023-04-28
Health check-in — days 1–6 daily, dose 6Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2023-04-29
Health check-in — days 1–6 daily, dose 6Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2023-04-30
Health check-in — days 1–6 daily, dose 6Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2023-05-01
- 2023-05-02
- 2023-05-08
- 2023-05-11
- 2023-05-18
- 2023-06-01
- 2023-06-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-17 | Pfizer-BioNTech | |
| 2 | 2021-04-07 | Pfizer-BioNTech | |
| 3 | 2021-11-29 | Pfizer-BioNTech | No |
| 4 | 2022-05-19 | Pfizer-BioNTech | No |
| 5 | 2022-09-22 | Pfizer-BioNTech | No |
| 6 | 2023-04-27 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Minor tenderness at injection siteno worse than annual influenza vaccination
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Tenderness at injection site but no worse than annual flu injection
Systemic reaction (other): Mild tenderness at injection site and in axillary area on same side as injection site.
Systemic reaction (other): Minimal tenderness in axillary area on same side as injection; injection site tenderness has subsided/ disappeared now.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swelling is if axillary lymph nodes on the side of the injection; less tenderness at actual injection site
Systemic reaction (other): Generalized arm ache/ pain greatly diminished almost gone; still tender at injection site; axillary lymph nodes remain swollen/ tender on side of injection but continues to diminish
Systemic reaction (other): Generalized arm soreness, injection site tenderness continues to diminish and almost gone; axillary lymph node on side of injection site are still swollen and tender but gradually diminishing
Systemic reaction (other): General arm soreness and injection site pain gone; axillary tenderness gone however lymph node swelling still present but appears to be diminishing
Systemic reaction (other): axillary swelling on side of injection continues to diminish; non- tender
Release 10 — day 7, dose 3
Systemic reaction (other): Axillary swelling on side of the injection continues to diminish; non- tender
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Axillary node tenderness on side of the injection
Systemic reaction (other): ***pinkened, itchy are surrounding injection site; axillary nodal tenderness on side of injection noted on Saturday following Thursday vaccination however not noted till after had already submitted V- safe check in; persisted thru today-lessening
Release 11 — day 7, dose 4
Systemic reaction (other): I tried to answer this Thursday when it came however was away from home and your app wouldn't let me so I am answering Thursday's questions today from home.
Release 12 — day 35, dose 4
Symptoms: 1 week duration violent productive cough difficult to control, no fever, negative at home Covid tests, fatigue, diagnosed and treated from Urgent Care as acute viral bronchitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis viral | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site pruritus | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
| SRO | Reaction to previous exposure to any vaccine | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release